| 000 | 01899cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 121218s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.03.Ph.D.2012.Al.R | ||
| 100 | 0 | _aAlaa Abdalhamid Mohammed Ali | |
| 245 | 1 | 4 |
_aThe relation between plasma concentration of osteopontin and matrix metalloproteinase-2 and severity of chronic heart failure / _cAlaa Abdalhamid Mohammed Ali ; Supervised Amina Kamal Eldein Elansary , Yaser Ahmed Abdelhady , Salwa Fayez Hasan |
| 246 | 1 | 5 | _aالعلاقة بينتركيز الأوستيوبونتين و الميتالوبروتينيز-2 فى البلازما و شدة فشل عضلة القلب المزمن |
| 260 |
_aCairo : _bAlaa Abdalhamid Mohammed Ali , _c2012 |
||
| 300 |
_a155 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry | ||
| 520 | _aExtracellular matrix remodeling is thought to play an important role in the progression of heart failure (HF). Matrix metalloproteinases-2 (MMPs) havebeen demonstrated to influence left ventricular properties and serve as targets of potential anti-remodeling agents. osteopontin, a glycoprotein that can be detected in plasma, was found to be up regulated in several animal models of cardiac failure and may thus represent a new biomarker that facilitates risk stratification in patients with heart failure | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHeart failure | |
| 653 | 4 | _aMetalloproteinase-2 | |
| 653 | 4 | _aOsteopontin | |
| 700 | 0 |
_aAmina Kamal Eldein Elansary , _eSupervisor |
|
| 700 | 0 |
_aSalwa Fayez Hasan , _eSupervisor |
|
| 700 | 0 |
_aYaser Ahmed Abdelhady , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40627 _d40627 |
||